This study aims to develop a highly sensitive, specific, and cost-effective blood assay for early detection of colorectal adenomas and cancer, using advanced m…

Colorectal CancerColorectal NeoplasmsColorectal Polyp+15 more

~Estimated

~$10 – $750

City of Hope Medical CenterNCT06342440

Phase 2

Phase II Trial of Pembrolizumab in Combination With Odetiglucan for Patients With Metastatic Colorectal Adenocarcinoma With Liver Predominant Disease

This study will evaluate the safety and effectiveness of the combination of pembrolizumab and odetiglucan in patients with metastatic colorectal cancer that is…

Colorectal Adenocarcinoma Metastatic in the Liver

~Estimated

~$10 – $6,250

Abramson Cancer Center at Penn MedicineNCT07082439